Serum Complement C3f and Fibrinopeptide A Are Potential Novel Diagnostic Biomarkers for Non-Alcoholic Fatty Liver Disease: A Study in Qingdao Twins

The discovery and identification of a candidate proteomic biomarker of active tuberculosis

(2013) Jiyan Liu et al.   BMC INFECTIOUS DISEASES

Proteomic and Lipidomic Signatures of Lipid Metabolism in NASH-Associated Hepatocellular Carcinoma

(2013) K. Muir et al.   CANCER RESEARCH

Peptides in Low Molecular Weight Fraction of Serum Associated with Hepatocellular Carcinoma

(2013) Yanming An et al.   DISEASE MARKERS

Complement C3f serum levels may predict breast cancer risk in women with gross cystic disease of the breast

(2013) Aldo Profumo et al.   Journal of Proteomics

Brain Derived Neurotrophic Factor (BDNF) levels as a possible predictor of psychopathology in healthy twins at high and low risk for affective disorder

(2013) Maj Vinberg et al.   PSYCHONEUROENDOCRINOLOGY

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma

(2011) Kohichiroh Yasui et al.   Clinical Gastroenterology and Hepatology

Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease

(2011) Chaohui Yu et al.   JOURNAL OF HEPATOLOGY

Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis

(2011) Hsin-Yi Yang et al.   NUTRITION

Plasma proteomic profiles from disease-discordant monozygotic twins suggest that molecular pathways are shared in multiple systemic autoimmune diseases*

(2011) Terrance P O'Hanlon et al.   ARTHRITIS RESEARCH & THERAPY

Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

(2010) Giovanni Musso et al.   ANNALS OF MEDICINE

Non-alcoholic fatty liver disease proteomics

(2010) Eva Rodríguez-Suárez et al.   Proteomics Clinical Applications

Proteome analysis of biological fluids from autoimmune-rheumatological disorders

(2010) Lucia De Franceschi et al.   Proteomics Clinical Applications

Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease

(2009) Lauren N. Bell et al.   HEPATOLOGY

Noninvasive Assessment of Hepatic Steatosis

(2008) Sameer M. Mazhar et al.   Clinical Gastroenterology and Hepatology

Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels

(2008) Yusuf Yilmaz et al.   HEPATOLOGY

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

(2008) Anna Ludovica Fracanzani et al.   HEPATOLOGY

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

(2008) Raj Vuppalanchi et al.   HEPATOLOGY